Key Highlights

  • HCA Healthcare (NYSE:HCA) reports before the open on Tuesday, October 27, 2026, against consensus earnings of USD 6.63 per share, after lowering its 2026 diluted earnings range to USD 28.70 to USD 30.50 on Tuesday, July 14, 2026.
  • Universal Health Services (NYSE:UHS) reports after the close against consensus adjusted earnings of USD 5.15 per share, with its 2026 adjusted range cut to USD 22.28 to USD 23.65 from USD 22.64 to USD 24.52.
  • Ensign (NASDAQ:ENSG) reports after the close against consensus of USD 1.97 per share, having raised 2026 guidance in July to diluted earnings of USD 7.75 to USD 7.85 per share.
  • Two of the three cut guidance in July and one raised it, and Medicaid payments, coverage losses and the September 16 rate increase to 3.75% to 4.00% are the shared drivers.

HCA Healthcare (NYSE:HCA): a lowered range sets the starting point

HCA Healthcare (NYSE:HCA), the largest for-profit hospital operator in the United States, reports third quarter 2026 results before the open on Tuesday, October 27, 2026. Consensus earnings are USD 6.63 per share. On Friday, July 24, 2026 it reported second quarter revenue of USD 20.23 billion, up 8.7%, adjusted earnings of USD 7.59 per share, up 11.0%, and adjusted EBITDA of USD 4.03 billion, a margin of 19.9%. Same-facility admissions rose 2.5%. Full-year guidance, set on Tuesday, July 14, 2026, is revenue of USD 77.0 billion to USD 79.5 billion and adjusted EBITDA of USD 15.4 billion to USD 16.1 billion. Results cannot be known in advance.

A hospital earns far more from a patient with private insurance than from an uninsured one, so payer mix can move profit even when admissions grow. HCA Healthcare estimated that coverage losses on the insurance exchanges cut second quarter pre-tax income by about USD 400 million, USD 75 million more than its first quarter estimate, offset by a similar gain from Medicaid supplemental payment programmes, mainly in Florida. Surgical volume was also lower.

The bull case is earnings above USD 6.63, admissions growth above 2.5% and a range that holds the USD 28.70 lower bound. The bear case is higher uninsured volume, a second cut to the range or supplemental payments that fall short of the offset. No options-implied move was found. Commentary on exchange coverage losses and surgical volume would be scrutinised closely, and the outlook for 2027 payer mix is likely to drive the shares more than the quarterly figure.

Universal Health Services (NYSE:UHS): a lower bar after a Florida one-off

Universal Health Services (NYSE:UHS) operates acute care hospitals and behavioural health facilities, and it reports third-quarter results after the close on Tuesday, October 27, 2026. Consensus adjusted earnings are USD 5.15 per share, against diluted earnings of USD 5.98 in the second quarter, reported on Monday, July 27, 2026 with net revenues up 8.3% to USD 4.638 billion. That quarter included a net pre-tax benefit of about USD 72 million from a Florida Medicaid directed payment, net of higher liability reserves. A call on Wednesday, October 28 is likely, based on the pattern of the last report.

Same-facility acute care adjusted admissions rose 2.9% and revenue per adjusted admission rose 3.0%, while behavioural health adjusted admissions rose 0.5%. First-half adjusted earnings were USD 11.60 per share, so by simple arithmetic the revised range implies USD 10.68 to USD 12.05 for the second half. The forecast adds no further Florida benefit beyond September 30, 2025, so federal approval of the larger programme is a potential upside.

The bull case is earnings above USD 5.15 and a range that holds its midpoint. The bear case is a shortfall, a further cut, higher professional liability reserves or weaker behavioural volumes, which could lead to a fall because the July cut already lowered confidence.

Ensign (NASDAQ:ENSG): occupancy and Texas integration

Ensign Group (NASDAQ:ENSG), an operator of skilled nursing and senior living facilities, reports third-quarter 2026 results after the close on Tuesday, October 27, 2026, so the first full trading reaction falls on Wednesday, October 28. Consensus adjusted earnings are USD 1.97 per share, USD 0.05 above the second-quarter adjusted figure of USD 1.92, up 20.8%, on revenue of USD 1.44 billion, up 17.3%. Guidance was raised to revenue of USD 5.87 billion to USD 5.92 billion from USD 5.81 billion to USD 5.86 billion. Results cannot be known in advance.

The company earns most of its profit from occupancy and skilled mix, the share of revenue from higher-paying Medicare and managed care patients. Same-facility occupancy was 84.1% and skilled mix revenue rose 10.1%. Management also cited weak occupancy and clinical challenges at newly acquired Texas facilities, which it expects will take time to resolve. It now runs 398 operations across 17 states.

The bull case is earnings at or above consensus, occupancy near 84% and a further lift to the range. The bear case is slower Texas progress, softer skilled mix or an unchanged range, which could prompt a pullback in a stock priced for steady execution. Medicare payment rules and state funding are the main policy risks. The company has a recent record of raising guidance, which raises the bar for each report, and the guidance midpoint of USD 7.80 implies a stronger second half than the second quarter.

Where Things Stand

The answer is that payer mix and public payments decide margins, and the three show it differently. HCA Healthcare (NYSE:HCA) needs to show that uninsured volume has stabilised and that the lowered range of USD 28.70 to USD 30.50 is safe against the USD 6.63 bar. Universal Health Services (NYSE:UHS) faces a USD 5.15 bar that reflects its lowered forecast, so admissions and the Medicaid outlook matter more than a small beat. Ensign (NASDAQ:ENSG) can clear USD 1.97 if occupancy and skilled mix hold, with Texas commentary likely to carry more weight.

The next catalysts are the HCA Healthcare release before the open on Tuesday, October 27, 2026, the Universal Health Services and Ensign releases after the close, and the Federal Reserve decision on Wednesday, October 28, 2026, after the rate rise on Wednesday, September 16, 2026. Hospital and care provider results also carry read-across for each other, since coverage rules, Medicaid funding and financing costs reach all three. Estimates and guidance are not guarantees, and this is not investment advice.